M2 PRESSWIRE-April 21, 2017-Immunoassay Systems – Global Strategic Business Report 2017 – Growing Popularity of Multiplexing Deters ELISA Market
(C)1994-2017 M2 COMMUNICATIONS
RDATE:21042017
Dublin – Research and Markets has announced the addition of the “Immunoassay Systems – Global Strategic Business Report” report to their offering.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for Immunoassay Systems in US$ Thousand by the following Technology Segments:
– Enzyme Immunoassay
– Fluorescence Immunoassay
– Chemiluminescence Immunoassay
– Rapid Tests
– ELISPOT
– PCR
– Others.
The report profiles 65 companies including many key and niche players such as:
– Abbott Laboratories (USA)
– Beckman Coulter, Inc. (USA)
– bioM?rieux SA (France)
– Bio-Rad Laboratories Inc. (USA)
– DiaSorin S.p.A (Italy)
– Fujirebio, Inc. (Japan)
– Ortho-Clinical Diagnostics, Inc. (USA)
– Roche Diagnostics (Switzerland)
– Siemens Healthineers (USA)
– Sysmex Corporation (Japan)
– Quidel Corporation (USA)
– Tosoh Bioscience, Inc. (USA)
Key Topics Covered:
1. INDUSTRY OVERVIEW
2. COMPETITIVE LANDSCAPE
3. MARKET TRENDS AND ISSUES
4. MACRO GROWTH DRIVERS AND APPLICATION MARKETS
5. CONCEPTUAL OVERVIEW
6. PRODUCT LAUNCHES/APPROVALS
7. RECENT INDUSTRY ACTIVITY
8. FOCUS ON SELECT MARKET PARTICIPANTS
9. GLOBAL MARKET PERSPECTIVE
Total Companies Profiled: 65 (including Divisions/Subsidiaries 88)
– The United States (49)
– Canada (1) Japan (7)
– Europe (29)
– France (3)
– Germany (6)
– The United Kingdom (5)
– Italy (3)
– Spain (1)
– Rest of Europe (11)
– Asia-Pacific (Excluding Japan) (2)
For more information about this report visit http://www.researchandmarkets.com/research/cbcs3w/immunoassay